Clinical Trial Update: Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 3]

View source ↗

Summary

This Phase 3 study evaluates the effectiveness and safety of ocrelizumab in people with early-stage relapsing-remitting multiple sclerosis; the trial was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Ocrevus (ocrelizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 3 | Status: TERMINATED | Results posted: 2025-01-15